Wealth Enhancement Advisory Services, LLC Ventyx Biosciences, Inc. Transaction History
Wealth Enhancement Advisory Services, LLC
- $49 Billion
- Q1 2025
A detailed history of Wealth Enhancement Advisory Services, LLC transactions in Ventyx Biosciences, Inc. stock. As of the latest transaction made, Wealth Enhancement Advisory Services, LLC holds 24,483 shares of VTYX stock, worth $33,786. This represents 0.0% of its overall portfolio holdings.
Number of Shares
24,483Holding current value
$33,786% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding VTYX
# of Institutions
132Shares Held
52.8MCall Options Held
63.4KPut Options Held
78.5K-
Black Rock Inc. New York, NY4.77MShares$6.58 Million0.0% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il4.48MShares$6.18 Million0.0% of portfolio
-
Bank Of America Corp Charlotte, NC4.27MShares$5.9 Million0.0% of portfolio
-
Sio Capital Management, LLC New York, NY4.05MShares$5.58 Million3.31% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.51MShares$4.85 Million0.0% of portfolio
About Ventyx Biosciences, Inc.
- Ticker VTYX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 56,527,200
- Market Cap $78M
- Description
- Ventyx Biosciences, Inc., a clinical-stage biopharmaceutical company, develops small molecule product candidates for inflammatory diseases and autoimmune disorders. The company's lead product candidate is VTX958, a tyrosine kinase type 2 inhibitor that is in phase I clinical trials for the treatment of immune-mediated diseases, such as psoriasis...